These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2866492)

  • 1. Antihypertensive therapy with once-daily administration of terazosin, a new alpha 1-adrenergic-receptor blocker.
    Abraham PA; Halstenson CE; Matzke GR; Napier JL; Keane WF
    Pharmacotherapy; 1985; 5(5):285-9. PubMed ID: 2866492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terazosin: an effective once-daily monotherapy for the treatment of hypertension.
    Dauer AD
    Am J Med; 1986 May; 80(5B):29-34. PubMed ID: 2872804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with terazosin administered in combination with other antihypertensive agents.
    Chrysant SG
    Am J Med; 1986 May; 80(5B):55-61. PubMed ID: 2872808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the safety and efficacy of once-daily terazosin versus twice-daily prazosin for the treatment of mild to moderate hypertension.
    Deger G
    Am J Med; 1986 May; 80(5B):62-7. PubMed ID: 2872809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of intravenous terazosin in hypertensive patients. A preliminary report.
    Cohen A
    Am J Med; 1986 May; 80(5B):86-93. PubMed ID: 2872814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative trials of terazosin with other antihypertensive agents.
    Ruoff G
    Am J Med; 1986 May; 80(5B):42-8. PubMed ID: 2872806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of terazosin on serum lipids.
    Deger G
    Am J Med; 1986 May; 80(5B):82-5. PubMed ID: 2872813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant administration of terazosin and atenolol for the treatment of essential hypertension.
    Holtzman JL; Kaihlanen PM; Rider JA; Lewin AJ; Spindler JS; Oberlin JA
    Arch Intern Med; 1988 Mar; 148(3):539-43. PubMed ID: 3277569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive effectiveness of terazosin: a new long-acting alpha-adrenergic inhibitor.
    Chrysant SG; Bal IS; Johnson B; McPherson MA
    Clin Cardiol; 1985 Sep; 8(9):486-9. PubMed ID: 2864153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of terazosin as an antihypertensive agent.
    Luther RR; Glassman HN; Jordan DC; Sperzel WD
    Am J Med; 1986 May; 80(5B):73-6. PubMed ID: 2872811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Felodipine versus prazosin as an addition to a beta-blocker in the treatment of essential hypertension. The Australian Multicentre Study.
    Jackson B; Morgan TO; Gibson J; Anderson A
    Drugs; 1987; 34 Suppl 3():109-19. PubMed ID: 2894971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of terazosin and enalapril on laboratory stress testing blood pressure in patients with essential hypertension.
    Cardillo C; Degen C; Campia U; De Felice F; Folli G
    J Clin Pharmacol; 1993 May; 33(5):433-8. PubMed ID: 8101194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terazosin: ex vivo and in vitro platelet aggregation effects in patients with arterial hypertension.
    Hernández Hernández R; Angeli-Greaves M; Carvajal AR; Guerrero Pajuelo J; Armas Padilla MC; Armas-Hernández MJ
    Am J Hypertens; 1996 May; 9(5):437-44. PubMed ID: 8735174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of terazosine and atenolol on serum lipids in essential hypertension].
    Bur A; Woisetschläger C; Herkner H; Derhaschnig U; Quehenberger P; Hirschl MM
    Z Kardiol; 2002 Sep; 91(9):685-92. PubMed ID: 12448067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of terazosin and methyclothiazide on blood pressure and serum lipids.
    Luther RR; Glassman HN; Estep CB; Maurath CJ; Jordan DC
    Am Heart J; 1989 Apr; 117(4):842-7. PubMed ID: 2564723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cumulative experience with terazosin administered in combination with diuretics.
    Rudd P
    Am J Med; 1986 May; 80(5B):49-54. PubMed ID: 2872807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term experience with terazosin for treatment of mild to moderate hypertension.
    Mersey JH
    Am J Med; 1986 May; 80(5B):68-72. PubMed ID: 2872810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of withdrawal of terazosin therapy in patients with hypertension.
    Ruoff G
    Am J Med; 1986 May; 80(5B):35-41. PubMed ID: 2872805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
    Itskovitz HD
    Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-1 adrenoceptor blockade with doxazosin in hypertension: effects on blood pressure and lipoproteins.
    Ames RP; Kiyasu JY
    J Clin Pharmacol; 1989 Feb; 29(2):123-7. PubMed ID: 2565917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.